Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse  >  Bristol-Myers Squibb Co    BMY

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
08/24/2015 08/25/2015 08/26/2015 08/27/2015 08/28/2015 Date
58.65(c) 57.88(c) 60.03(c) 60.82(c) 60.61(c) Last
15 215 037 8 146 154 10 246 517 7 446 914 5 304 836 Volume
-3.96% -1.31% +3.71% +1.32% -0.35% Change
More quotes
Financials ($)
Sales 2015 15 984 M
EBIT 2015 3 431 M
Net income 2015 2 566 M
Finance 2015 2 130 M
Yield 2015 2,47%
Sales 2016 16 802 M
EBIT 2016 4 068 M
Net income 2016 3 765 M
Finance 2016 2 068 M
Yield 2016 2,54%
PER 2015 46,36
PER 2016 26,99
EV / Sales 2015 6,19x
EV / Sales 2016 5,89x
Capitalization 101 067 M
More Financials
Company
Bristol-Myers Squibb Co. is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products.Its pharmaceutical products include chemically-synthesized drugs or small molecules and an increasing portion of products produced from... 
Sector
Pharmaceuticals
Calendar
10/21Earnings Release
More about the company
Surperformance© ratings of Bristol-Myers Squibb Co
Trading Rating : Investor Rating :
More Ratings
Latest news on BRISTOL-MYERS SQUIBB CO
08/27 BRISTOL MYERS SQUIBB : Trademark Application for "TRIMOX" Filed by Bristol-Myers..
08/27 BRISTOL MYERS SQUIBB : New Labelled Compounds and Radiopharmaceuticals Data Have..
08/27 BRISTOL MYERS SQUIBB : Investigators at Bristol-Myers Squibb Report Findings in ..
08/27DJALLIED MINDS : -Bristol Life Sciences Licenses Technology and Molecules from Yal..
08/27 ALLIED MINDS : Says Bristol-Myers Squibb Venture Signs Deal With Yale
08/27 BRISTOL MYERS SQUIBB : and Pfizer to Report New Data on Eliquis (apixaban)
08/27 BRISTOL MYERS SQUIBB : and Pfizer to Participate at the ESC Congress 2015
08/27 BRISTOL MYERS SQUIBB : and Pfizer to Report New Data on Eliquis (apixaban) at ES..
More news
Sector news : Pharmaceuticals - NEC
08/30 ASTRAZENECA : Medimmune enters into strategic cancer vaccine collaboration and l..
08/29 PERRIGO : mylan perrigo shareholder vote 8-28 pq jsm
08/29 Largest Dutch pension fund exits Mylan over death penalty concerns
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
08/25 The Generation Portfolio
08/24 Chowder #, CAGR To Trim 100+ Stocks To <70 And Evaluate For Repurchase
08/24 BUYING AMID THE SELLOFF, PHARMA M&A, : SA Biotech Panel Discussion
08/24 Is The Heat Of This Correction Too Much? Get Out Of The Kitchen Or Start Nibb..
08/20 A REVIEW OF GILEAD'S PIPELINE (PART : Focus On Zydelig And Lymphoma/CLL Candida..


Comments 
Advertisement
Chart BRISTOL-MYERS SQUIBB CO
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Full-screen chart
Technical analysis trends BRISTOL-MYERS SQU...
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions